Sfoglia per Autore
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis
2015-01-01 Vincenzi, B.; Di Maio, M.; Silletta, M.; D'Onofrio, L.; Spoto, C.; Piccirillo, M. C.; Daniele, G.; Comito, F.; Maci, E.; Bronte, G.; Russo, A.; Santini, D.; Perrone, F.; Tonini, G.
Cancer and the microbiome: Potential applications as new tumor biomarker
2015-01-01 Shahanavaj, K.; Gil-Bazo, I.; Castiglia, M.; Bronte, G.; Passiglia, F.; Carreca, A. P.; Del Pozo, J. L.; Russo, A.; Peeters, M.; Rolfo, C.
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy
2015-01-01 Bronte, G.; Lo Vullo, F.; Pernice, G.; Galvano, A.; Fiorentino, E.; Cicero, G.; Bazan, V.; Rolfo, C.; Russo, A.
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS?
2015-01-01 Bronte, G.; Silvestris, N.; Castiglia, M.; Galvano, A.; Passiglia, F.; Sortino, G.; Cicero, G.; Rolfo, C.; Peeters, M.; Bazan, V.; Fanale, D.; Giordano, A.; Russo, A.
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls?
2015-01-01 Passiglia, F.; Bronte, G.; Castiglia, M.; Listi, A.; Calo, V.; Toia, F.; Cicero, G.; Fanale, D.; Rizzo, S.; Bazan, V.; Russo, A.
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment
2015-01-01 Bronte, E.; Bronte, G.; Novo, G.; Bronte, F.; Bavetta, M. G.; Re, G. L.; Brancatelli, G.; Bazan, V.; Natoli, C.; Novo, S.; Russo, A.
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients
2015-01-01 Vincenzi, B.; Cremolini, C.; Sartore-Bianchi, A.; Russo, A.; Mannavola, F.; Perrone, G.; Pantano, F.; Loupakis, F.; Rossini, D.; Ongaro, E.; Bonazzina, E.; Dell'Aquila, E.; Imperatori, M.; Zoccoli, A.; Bronte, G.; Maglio, G. D.; Fontanini, G.; Natoli, C.; Falcone, A.; Santini, D.; Onetti-Muda, A.; Siena, S.; Tonini, G.; Aprile, G.
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option?
2015-01-01 Fanale, D.; Bronte, G.; Passiglia, F.; Calo, V.; Castiglia, M.; Di Piazza, F.; Barraco, N.; Cangemi, A.; Catarella, M. T.; Insalaco, L.; Listi, A.; Maragliano, R.; Massihnia, D.; Perez, A.; Toia, F.; Cicero, G.; Bazan, V.
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy
2015-01-01 Bronte, G.; Bronte, E.; Novo, G.; Pernice, G.; Lo Vullo, F.; Musso, E.; Bronte, F.; Gulotta, E.; Rizzo, S.; Rolfo, C.; Silvestris, N.; Bazan, V.; Novo, S.; Russo, A.
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward
2015-01-01 Papadimitriou, K.; Antoniou, G.; Rolfo, C.; Russo, A.; Bronte, G.; Vassiliou, V.; Papamichael, D.; Peeters, M.; Kountourakis, P.
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis
2015-01-01 Bronte, G.; Rolfo, C.; Passiglia, F.; Rizzo, S.; Gil-Bazo, I.; Fiorentino, E.; Cajozzo, M.; Van Meerbeeck, J. P.; Lequaglie, C.; Santini, D.; Pauwels, P.; Russo, A.
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario
2015-01-01 Bronte, G.; Sortino, G.; Passiglia, F.; Rizzo, S.; Lo Vullo, F.; Galvano, A.; Bazan, V.; Rolfo, C.; Russo, A.
VIPoma and PPoma
2015-01-01 Rolfo, C.; Papadimitriou, K.; Peeters, M.; Bronte, G.; Russo, A.; Leider, L.; Pauwels, P.
Nintedanib in NSCLC: Evidence to date and place in therapy
2016-01-01 Bronte, G.; Passiglia, F.; Galvano, A.; Barraco, N.; Listi, A.; Castiglia, M.; Rizzo, S.; Fiorentino, E.; Bazan, V.; Russo, A.
Multisciplinary management of patients with liver metastasis from colorectal cancer
2016-01-01 De Greef, K.; Rolfo, C.; Russo, A.; Chapelle, T.; Bronte, G.; Passiglia, F.; Coelho, A.; Papadimitriou, K.; Peeters, M.
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?
2016-01-01 Bronte, G.; Incorvaia, L.; Rizzo, S.; Passiglia, F.; Galvano, A.; Rizzo, F.; Rolfo, C.; Fanale, D.; Listi, A.; Natoli, C.; Bazan, V.; Russo, A.
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis
2016-01-01 Passiglia, F.; Bronte, G.; Bazan, V.; Natoli, C.; Rizzo, S.; Galvano, A.; Listi, A.; Cicero, G.; Rolfo, C.; Santini, D.; Russo, A.
Semi-automated volumetric analysis in the NELSON trial for lung cancer screening: Is there room for diagnostic experience yet
2016-01-01 Bronte, G.; Rolfo, C.
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus
2016-01-01 Cabibi, D.; Caruso, S.; Bazan, V.; Castiglia, M.; Bronte, G.; Ingrao, S.; Fanale, D.; Cangemi, A.; Calo, V.; Listi, A.; Incorvaia, L.; Galvano, A.; Pantuso, G.; Fiorentino, E.; Castorina, S.; Russo, A.
Dietary restriction: could it be considered as speed bump on tumor progression road?
2016-01-01 Cangemi, A.; Fanale, D.; Rinaldi, G.; Bazan, V.; Galvano, A.; Perez, A.; Barraco, N.; Massihnia, D.; Castiglia, M.; Vieni, S.; Bronte, G.; Mirisola, M.; Russo, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis | 1-gen-2015 | Vincenzi, B.; Di Maio, M.; Silletta, M.; D'Onofrio, L.; Spoto, C.; Piccirillo, M. C.; Daniele, G.; Comito, F.; Maci, E.; Bronte, G.; Russo, A.; Santini, D.; Perrone, F.; Tonini, G. | |
| Cancer and the microbiome: Potential applications as new tumor biomarker | 1-gen-2015 | Shahanavaj, K.; Gil-Bazo, I.; Castiglia, M.; Bronte, G.; Passiglia, F.; Carreca, A. P.; Del Pozo, J. L.; Russo, A.; Peeters, M.; Rolfo, C. | |
| Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy | 1-gen-2015 | Bronte, G.; Lo Vullo, F.; Pernice, G.; Galvano, A.; Fiorentino, E.; Cicero, G.; Bazan, V.; Rolfo, C.; Russo, A. | |
| New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? | 1-gen-2015 | Bronte, G.; Silvestris, N.; Castiglia, M.; Galvano, A.; Passiglia, F.; Sortino, G.; Cicero, G.; Rolfo, C.; Peeters, M.; Bazan, V.; Fanale, D.; Giordano, A.; Russo, A. | |
| Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? | 1-gen-2015 | Passiglia, F.; Bronte, G.; Castiglia, M.; Listi, A.; Calo, V.; Toia, F.; Cicero, G.; Fanale, D.; Rizzo, S.; Bazan, V.; Russo, A. | |
| What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment | 1-gen-2015 | Bronte, E.; Bronte, G.; Novo, G.; Bronte, F.; Bavetta, M. G.; Re, G. L.; Brancatelli, G.; Bazan, V.; Natoli, C.; Novo, S.; Russo, A. | |
| Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients | 1-gen-2015 | Vincenzi, B.; Cremolini, C.; Sartore-Bianchi, A.; Russo, A.; Mannavola, F.; Perrone, G.; Pantano, F.; Loupakis, F.; Rossini, D.; Ongaro, E.; Bonazzina, E.; Dell'Aquila, E.; Imperatori, M.; Zoccoli, A.; Bronte, G.; Maglio, G. D.; Fontanini, G.; Natoli, C.; Falcone, A.; Santini, D.; Onetti-Muda, A.; Siena, S.; Tonini, G.; Aprile, G. | |
| Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? | 1-gen-2015 | Fanale, D.; Bronte, G.; Passiglia, F.; Calo, V.; Castiglia, M.; Di Piazza, F.; Barraco, N.; Cangemi, A.; Catarella, M. T.; Insalaco, L.; Listi, A.; Maragliano, R.; Massihnia, D.; Perez, A.; Toia, F.; Cicero, G.; Bazan, V. | |
| Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy | 1-gen-2015 | Bronte, G.; Bronte, E.; Novo, G.; Pernice, G.; Lo Vullo, F.; Musso, E.; Bronte, F.; Gulotta, E.; Rizzo, S.; Rolfo, C.; Silvestris, N.; Bazan, V.; Novo, S.; Russo, A. | |
| Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward | 1-gen-2015 | Papadimitriou, K.; Antoniou, G.; Rolfo, C.; Russo, A.; Bronte, G.; Vassiliou, V.; Papamichael, D.; Peeters, M.; Kountourakis, P. | |
| What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis | 1-gen-2015 | Bronte, G.; Rolfo, C.; Passiglia, F.; Rizzo, S.; Gil-Bazo, I.; Fiorentino, E.; Cajozzo, M.; Van Meerbeeck, J. P.; Lequaglie, C.; Santini, D.; Pauwels, P.; Russo, A. | |
| Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario | 1-gen-2015 | Bronte, G.; Sortino, G.; Passiglia, F.; Rizzo, S.; Lo Vullo, F.; Galvano, A.; Bazan, V.; Rolfo, C.; Russo, A. | |
| VIPoma and PPoma | 1-gen-2015 | Rolfo, C.; Papadimitriou, K.; Peeters, M.; Bronte, G.; Russo, A.; Leider, L.; Pauwels, P. | |
| Nintedanib in NSCLC: Evidence to date and place in therapy | 1-gen-2016 | Bronte, G.; Passiglia, F.; Galvano, A.; Barraco, N.; Listi, A.; Castiglia, M.; Rizzo, S.; Fiorentino, E.; Bazan, V.; Russo, A. | |
| Multisciplinary management of patients with liver metastasis from colorectal cancer | 1-gen-2016 | De Greef, K.; Rolfo, C.; Russo, A.; Chapelle, T.; Bronte, G.; Passiglia, F.; Coelho, A.; Papadimitriou, K.; Peeters, M. | |
| The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? | 1-gen-2016 | Bronte, G.; Incorvaia, L.; Rizzo, S.; Passiglia, F.; Galvano, A.; Rizzo, F.; Rolfo, C.; Fanale, D.; Listi, A.; Natoli, C.; Bazan, V.; Russo, A. | |
| PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis | 1-gen-2016 | Passiglia, F.; Bronte, G.; Bazan, V.; Natoli, C.; Rizzo, S.; Galvano, A.; Listi, A.; Cicero, G.; Rolfo, C.; Santini, D.; Russo, A. | |
| Semi-automated volumetric analysis in the NELSON trial for lung cancer screening: Is there room for diagnostic experience yet | 1-gen-2016 | Bronte, G.; Rolfo, C. | |
| Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus | 1-gen-2016 | Cabibi, D.; Caruso, S.; Bazan, V.; Castiglia, M.; Bronte, G.; Ingrao, S.; Fanale, D.; Cangemi, A.; Calo, V.; Listi, A.; Incorvaia, L.; Galvano, A.; Pantuso, G.; Fiorentino, E.; Castorina, S.; Russo, A. | |
| Dietary restriction: could it be considered as speed bump on tumor progression road? | 1-gen-2016 | Cangemi, A.; Fanale, D.; Rinaldi, G.; Bazan, V.; Galvano, A.; Perez, A.; Barraco, N.; Massihnia, D.; Castiglia, M.; Vieni, S.; Bronte, G.; Mirisola, M.; Russo, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile